GENES THAT INCREASE PEPTIDE PRODUCTION
    61.
    发明申请
    GENES THAT INCREASE PEPTIDE PRODUCTION 审中-公开
    增加肽生产的基因

    公开(公告)号:US20100159513A1

    公开(公告)日:2010-06-24

    申请号:US12619790

    申请日:2009-11-17

    IPC分类号: C12P21/00 C12N1/21

    CPC分类号: C12P21/02

    摘要: Several endogenous genes have been identified in Escherichia coli, the overexpression of which increases recombinant peptide production. Increasing the copy number of aroB, aroK, proB, or crl increases the amount of a recombinant peptide produced by a host cell. Recombinant host cells comprising at least one chimeric genetic construct encoding a peptide of interest and at least one genetic modification that increases recombinant peptide production are provided as well as methods of using such recombinant host cells

    摘要翻译: 已经在大肠杆菌中鉴定了几种内源基因,其过表达增加了重组肽的产生。 增加aroB,aroK,proB或crl的拷贝数增加了由宿主细胞产生的重组肽的量。 提供了包含至少一种编码目的肽的嵌合基因构建体和至少一种提高重组肽产生的遗传修饰的重组宿主细胞以及使用这种重组宿主细胞的方法

    Compiler and Runtime for Heterogeneous Multiprocessor Systems
    66.
    发明申请
    Compiler and Runtime for Heterogeneous Multiprocessor Systems 有权
    用于异构多​​处理器系统的编译器和运行时

    公开(公告)号:US20090158248A1

    公开(公告)日:2009-06-18

    申请号:US11958307

    申请日:2007-12-17

    IPC分类号: G06F9/44

    CPC分类号: G06F9/505 G06F2209/5017

    摘要: Presented are embodiments of methods and systems for library-based compilation and dispatch to automatically spread computations of a program across heterogeneous cores in a processing system. The source program contains a parallel-programming keyword, such as mapreduce, from a high-level, library-oriented parallel programming language. The compiler inserts one or more calls for a generic function, associated with the parallel-programming keyword, into the compiled code. A runtime library provides a predicate-based library system that includes multiple hardware specific implementations (“variants”) of the generic function. A runtime dispatch engine dynamically selects the best-available (e.g., most specific) variant, from a bundle of hardware-specific variants, for a given input and machine configuration. That is, the dispatch engine may take into account run-time availability of processing elements, choose one of them, and then select for dispatch an appropriate variant to be executed on the selected processing element. Other embodiments are also described and claimed.

    摘要翻译: 提出了用于基于库的编译和调度的方法和系统的实施例,以便在处理系统中跨异构核心自动扩展程序的计算。 源程序包含一个并行编程关键字,如mapreduce,来自高级的面向库的并行编程语言。 编译器将一个或多个与并行编程关键字关联的通用函数的调用插入到编译代码中。 运行时库提供了一个基于谓词的库系统,它包含通用函数的多个硬件特定实现(“变体”)。 对于给定的输入和机器配置,运行时调度引擎从一组特定于硬件的变体动态地选择最佳可用(例如,最具体的)变体。 也就是说,调度引擎可以考虑处理元件的运行时间可用性,选择其中之一,然后选择在所选择的处理元件上调度要执行的适当变体。 还描述和要求保护其他实施例。

    Treatment of pancreatitis using alpha 7 receptor-binding cholinergic agonists
    68.
    发明申请
    Treatment of pancreatitis using alpha 7 receptor-binding cholinergic agonists 有权
    使用α7受体结合胆碱能激动剂治疗胰腺炎

    公开(公告)号:US20090123456A1

    公开(公告)日:2009-05-14

    申请号:US11724605

    申请日:2007-03-15

    摘要: A method of treating a patient suffering from pancreatitis comprising treating said patient with a therapeutically effective amount of a cholinergic agonist selective for an α7 nicotinic receptor in an amount sufficient to decrease the amount of the proinflammatory cytokine that is released from a macrophage wherein said condition is acute pancreatitis. The compounds of the present invention include a quaternary analog of cocaine; (1-aza-bicyclo[2.2.2]oct-3-yl)-carbamic acid 1-(2-fluorophenyl)-ethyl ester; a compound of formula (I), a compound of formula (II), a compound of formula (III), a compound of formula (IV), and an oligonucleotide or mimetic capable of attenuating the symptoms of acute pancreatitis wherein the oligonucleotide or mimetic consists essentially of a sequence greater than 5 nucleotides long that is complementary to an mRNA of an α7 cholinergic receptor. The variables of formulae (I), (II), (III) and (IV) are described herein.

    摘要翻译: 一种治疗患有胰腺炎的患者的方法,其包括以足以减少从巨噬细胞释放的促炎细胞因子的量的治疗有效量的对α7烟碱受体选择性的胆碱能激动剂治疗所述患者,其中所述病症是 急性胰腺炎。 本发明的化合物包括可卡因的四元类似物; (1-氮杂 - 双环[2.2.2]辛-3-基) - 氨基甲酸1-(2-氟苯基) - 乙酯; 式(I)化合物,式(II)化合物,式(III)化合物,式(IV)化合物和能够减弱急性胰腺炎症状的寡核苷酸或模拟物,其中寡核苷酸或模拟物 基本上由大于5个核苷酸长的序列组成,其与α7胆碱能受体的mRNA互补。 本文描述了式(I),(II),(III)和(IV)的变量。

    Isoflavone Glycosides as Peroxisome Proliferator-Activated Receptor-alpha Modulator
    69.
    发明申请
    Isoflavone Glycosides as Peroxisome Proliferator-Activated Receptor-alpha Modulator 审中-公开
    异黄酮糖苷作为过氧化物酶体增殖物激活受体-α调节剂

    公开(公告)号:US20090099099A1

    公开(公告)日:2009-04-16

    申请号:US11872771

    申请日:2007-10-16

    IPC分类号: A61K31/7048 C07H3/02 A61P3/04

    CPC分类号: C07H3/02

    摘要: A method of treating or preventing diseases related to modulation of PPAR-α in comprising administering to a human or other mammals in need of such treatment an effective amount of plant material derived from plants of the genera Puerila Lobata.

    摘要翻译: 一种治疗或预​​防与PPAR-α调节有关的疾病的方法,其包括对需要这种治疗的人或其他哺乳动物施用有效量的源自普拉里巴拉杜鹃属植物的植物材料。